Señales en vivo de MCAP.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 10:03):

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout...

Stats
Volumen de hoy	15 207.00
Volumen promedio	13 860.00
Capitalización de mercado	6.91B
EPS	SEK0 ( 2024-05-02 )
Próxima fecha de ganancias	( SEK0 ) 2024-07-19
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	40.22
ATR14	SEK0.933 (0.20%)

Volumen Correlación

Largo: -0.03 (neutral)

Corto: -0.12 (neutral)

Signal:(34.348) Neutral

MedCap AB (publ) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MedCap AB (publ) Correlación - Moneda/Commodity

0.22
( neutral )

-0.32
( neutral )

0.34
( neutral )

0.10
( neutral )

0.37
( neutral )

-0.45
( neutral )

MedCap AB (publ) Finanzas

Annual	2023
Ingresos:	SEK1.59B
Beneficio Bruto:	SEK221.50M (13.95 %)
EPS:	SEK11.63

FY	2023
Ingresos:	SEK1.59B
Beneficio Bruto:	SEK221.50M (13.95 %)
EPS:	SEK11.63

FY	2022
Ingresos:	SEK1.11B
Beneficio Bruto:	SEK462.40M (41.61 %)
EPS:	SEK7.94

FY	2021
Ingresos:	SEK916.30M
Beneficio Bruto:	SEK369.80M (40.36 %)
EPS:	SEK0.920

Financial Reports:

No articles found.

MedCap AB (publ)

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe. It typically invests between SEK25 million ($2.75 million) to SEK150 million ($16.51 million) with enterprise value and sales revenue between SEK50 million ($5.90 million) to SEK200 million ($23.06 million) and EBITDA between SEK1 million ($0.11 million) to SEK50 million ($5.50 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.